Incyte Corporation INCY announced today it will present at the 33rd Annual J. P. Morgan Healthcare Conference on Monday, January 12th at 8:30 a.m. (PST) / 11:30 a.m. (EST) in San Francisco.
The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs, primarily for oncology. For additional information on Incyte, please visit the Company's website at www.incyte.com.
Incyte Corporation
Pamela M. Murphy
Vice
President, Investor Relations & Corporate Communications
302-498-6944
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.